APA (7th ed.) Citation

Ganguly, T., Bauer, N., Davis, R. A., Foster, C. C., Harris, R. E., Hausner, S. H., . . . Sutcliffe, J. L. (2022). Preclinical evaluation of 68Ga- and 177Lu-labeled integrin αvβ6-targeting radiotheranostic peptides. Journal of Nuclear Medicine, 63(10), 1. https://doi.org/10.2967/jnumed.122.264749

Chicago Style (17th ed.) Citation

Ganguly, Tanushree, Nadine Bauer, Ryan A. Davis, Cameron C. Foster, Rebecca E. Harris, Sven H. Hausner, Emilie Roncali, Sarah Y. Tang, and Julie L. Sutcliffe. "Preclinical Evaluation of 68Ga- and 177Lu-labeled Integrin αvβ6-targeting Radiotheranostic Peptides." Journal of Nuclear Medicine 63, no. 10 (2022): 1. https://doi.org/10.2967/jnumed.122.264749.

MLA (9th ed.) Citation

Ganguly, Tanushree, et al. "Preclinical Evaluation of 68Ga- and 177Lu-labeled Integrin αvβ6-targeting Radiotheranostic Peptides." Journal of Nuclear Medicine, vol. 63, no. 10, 2022, p. 1, https://doi.org/10.2967/jnumed.122.264749.